Can GLP-1 receptor agonists improve crude outcomes associated with heart failure? A meta-analysis of randomized controlled trials comprising 78,806 patients
The risk of sudden cardiac death and use of SGLT2 inhibitors in patients with heart failure: a meta-analysis of pivotal randomized controlled trials including 17,911 patients
Event:
Heart Failure 2023
Topic:
Cardiovascular Pharmacotherapy
Session:
ePosters in interventional cardiology and pharmacology